FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Welcoming Dr. Jonathan Friedberg as Lymphoma Committee Chair

Mar 28, 2014 - I'm very pleased to announce that Dr. Jonathan W. Friedberg has accepted my offer to become the next Chair of SWOG's Lymphoma Committee, taking the reins from Dr. Richard Fisher at the spring Group Meeting in San Francisco.

Dr. Friedberg has been an active member of SWOG since 2002. He currently serves as SWOG site PI for the University of Rochester. In addition to the many investigator-initiated studies he has led, Dr. Friedberg has also served as study chair or co-chair for a number of SWOG clinical trials, including S0433 and S0801, both of which added iodine-131 labeled tositumomab to R-CHOP for patients with advanced lymphoma, and S0816, which used FDG-PET imaging to adapt treatment course for Hodgkin lymphoma.

Dr. Friedberg is Director of the Wilmot Cancer Center at the University of Rochester, where he is Samuel Durand Professor of Medicine and Chief of Hematology/Oncology. He also directs the clinical trials core for the Lymphoma SPORE based at Rochester. He earned both an M.D. and an M.M.Sc. in Clinical Investigation from Harvard Medical School and completed residencies at Massachusetts General Hospital and fellowships at Dana-Farber and Harvard.

I would like to thank the Lymphoma Chair search committee, and its chair, Dr. Robert Orlowski, for their diligence in identifying several outstanding candidates for this critical role.

Please join me in wishing Dr. Friedberg success in charting a course for lymphoma research within SWOG and the NCTN for many years to come.

Related links


SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified